Personalized treatment prolongs the life of lung cancer patients

Mexican scientists have increased survival rates for patients diagnosed with lunch cancer in metastatic stage (when the disease has spread to different parts of the body) from a rate of nine months of survival to 30 with personalized treatments. Tumor tissue samples were used to extract DNA in order to analyze mutations in the neoplasia (abnormal mass of tissue). Based on the mutations, personalized treatments were provided to the study participants.